Literature DB >> 21104822

Functional outcomes after extended surgery for gastric cancer.

Y Kurokawa1, M Sasako, T Sano, T Shibata, S Ito, A Nashimoto, A Kurita, T Kinoshita.   

Abstract

BACKGROUND: Extended gastrectomy with para-aortic nodal dissection (PAND) or thorough dissection of mediastinal nodes using a left thoracoabdominal (LTA) approach is an alternative to D2 lymphadenectomy, with variable postoperative results.
METHODS: Two randomized controlled trials have been conducted to compare D2 lymphadenectomy alone (263 patients) versus D2 lymphadenectomy plus PAND (260), and the abdominal-transhiatal (TH) approach (82) versus the LTA approach (85), in patients with gastric cancer. Prospectively registered secondary endpoints bodyweight, symptom scores and respiratory function were evaluated in the present study.
RESULTS: Bodyweight was comparable after D2 and D2 plus PAND, but higher after TH than after LTA procedures at 1 and 3 years. At 1- and 3-year follow-up symptom scores were comparable between D2 and D2 plus PAND. A LTA approach resulted in significantly worse scores than a TH approach in terms of meal volume, return to work, incisional pain and dyspnoea up to 1 year. The decrease in vital capacity was significantly greater after LTA than TH procedures up to 6 months.
CONCLUSION: Bodyweight and postoperative symptoms were not affected by adding PAND to a D2 procedure. A LTA approach aggravated weight loss, symptoms and respiratory functions compared with a TH approach.

Entities:  

Mesh:

Year:  2011        PMID: 21104822     DOI: 10.1002/bjs.7297

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Kohei Murakami; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-10-19       Impact factor: 2.549

2.  A commentary on "Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia".

Authors:  Shinji Mine; Masayuki Watanabe
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

3.  Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach.

Authors:  Naveena An Kumar; Ashwin Desouza; Manish S Bhandare; Jagan R Murugan; Gaurav Khandelwal; Vikram Chaudhari; Vikas Ostwal; Shailesh V Shrikhande
Journal:  Langenbecks Arch Surg       Date:  2020-11-26       Impact factor: 3.445

4.  Prognostic Significance of Hiatal Hernia in Patients with Gastric Cancer Located within the Upper-Third of the Stomach.

Authors:  Suguru Maruyama; Yoshihiko Kawaguchi; Hidenori Akaike; Kensuke Shiraishi; Ryo Saito; Hiroki Shimizu; Shinji Furuya; Naohiro Hosomura; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

5.  Effect of Patient-Participation Continuous Nutritional Counseling in Gastric Cancer Patients who Underwent Gastrectomy.

Authors:  Nobuo Takata; Satoru Kikuchi; Shinji Kuroda; Shunsuke Tanabe; Naoaki Maeda; Kazuhiro Noma; Ayako Takahashi; Yuzo Umeda; Kenichi Shikata; Kazuhide Ozaki; Toshiyoshi Fujiwara
Journal:  Ann Surg Oncol       Date:  2022-09-25       Impact factor: 4.339

6.  Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial.

Authors:  Yasuhiro Miyazaki; Takeshi Omori; Kazumasa Fujitani; Junya Fujita; Ryohei Kawabata; Hiroshi Imamura; Kazuyuki Okada; Jeong-Ho Moon; Motohiro Hirao; Jin Matsuyama; Takuro Saito; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2021-04-09       Impact factor: 7.370

7.  Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer.

Authors:  Hongshan Wang; Heng Zhang; Cong Wang; Yong Fang; Xuefei Wang; Weidong Chen; Fenglin Liu; Kuntang Shen; Xinyu Qin; Zhenbin Shen; Yihong Sun
Journal:  Chin J Cancer Res       Date:  2016-06       Impact factor: 5.087

8.  Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.

Authors:  Y Kurokawa; M Sasako; T Sano; T Yoshikawa; Y Iwasaki; A Nashimoto; S Ito; A Kurita; J Mizusawa; K Nakamura
Journal:  Br J Surg       Date:  2015-01-21       Impact factor: 6.939

9.  Comparisons of Clinical Outcomes and Prognoses in Patients With Gastroesophageal Junction Adenocarcinoma, by Transthoracic and Transabdominal Hiatal Approaches: A Teaching Hospital Retrospective Cohort Study.

Authors:  Jinzhe Zhou; Hao Wang; Zhaojian Niu; Dong Chen; Dongsheng Wang; Liang Lv; Yu Li; Jian Zhang; Shougen Cao; Yi Shen; Yanbing Zhou
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

10.  Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma.

Authors:  Joonas H Kauppila; Cecilia Ringborg; Asif Johar; Jesper Lagergren; Pernilla Lagergren
Journal:  Gastric Cancer       Date:  2017-08-29       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.